Filing Details
- Accession Number:
- 0001213900-18-002139
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-20 20:00:08
- Reporting Period:
- 2018-02-13
- Accepted Time:
- 2018-02-20 20:00:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 948320 | Immudyne Inc. | IMMD | Medicinal Chemicals & Botanical Products (2833) | 760238453 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1721526 | Mark Mclaughlin | 50 Spring Meadow Road Mount Kisco NY 10549 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 | Disposition | 2018-02-13 | 1,130,436 | $0.23 | 2,640,507 | No | 4 | D | Direct | |
| Common Stock, Par Value $0.01 | Disposition | 2018-02-13 | 298,407 | $0.23 | 2,342,100 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.01 | Disposition | 2018-02-13 | 100,000 | $0.23 | 1,040,000 | No | 4 | S | Indirect | McLaughlin International, Inc. |
| Common Stock, Par Value $0.01 | Disposition | 2018-02-13 | 190,000 | $0.23 | 54,228 | No | 4 | S | Indirect | Bruni McLaughlin - Spouse |
| Common Stock, Par Value $0.01 | Disposition | 2018-02-13 | 217,391 | $0.23 | 512,284 | No | 4 | D | Indirect | Genevieve McLaughlin - Daughter |
| Common Stock, Par Value $0.01 | Disposition | 2018-02-13 | 5,504 | $0.23 | 506,780 | No | 4 | S | Indirect | Genevieve McLaughlin - Daughter |
| Common Stock, Par Value $0.01 | Disposition | 2018-02-13 | 217,391 | $0.23 | 553,284 | No | 4 | D | Indirect | James McLaughlin - Son |
| Common Stock, Par Value $0.01 | Disposition | 2018-02-13 | 15,000 | $0.23 | 538,284 | No | 4 | S | Indirect | James McLaughlin - Son |
| Common Stock, Par Value $0.01 | Disposition | 2018-02-13 | 31,504 | $0.23 | 506,780 | No | 4 | S | Indirect | James McLaughlin - Son |
| Common Stock, Par Value $0.01 | Disposition | 2018-02-13 | 217,391 | $0.23 | 538,362 | No | 4 | D | Indirect | Mark McLaughlin Jr. - Son |
| Common Stock, Par Value $0.01 | Disposition | 2018-02-13 | 31,582 | $0.23 | 506,780 | No | 4 | S | Indirect | Mark McLaughlin Jr. - Son |
| Common Stock, Par Value $0.01 | Disposition | 2018-02-13 | 217,391 | $0.23 | 634,784 | No | 4 | D | Indirect | Faith McLaughlin - Daughter |
| Common Stock, Par Value $0.01 | Disposition | 2018-02-13 | 96,593 | $0.23 | 538,191 | No | 4 | S | Indirect | Faith McLaughlin - Daughter |
| Common Stock, Par Value $0.01 | Disposition | 2018-02-13 | 31,410 | $0.23 | 506,781 | No | 4 | S | Indirect | Faith McLaughlin - Daughter |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | D | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | McLaughlin International, Inc. |
| No | 4 | S | Indirect | Bruni McLaughlin - Spouse |
| No | 4 | D | Indirect | Genevieve McLaughlin - Daughter |
| No | 4 | S | Indirect | Genevieve McLaughlin - Daughter |
| No | 4 | D | Indirect | James McLaughlin - Son |
| No | 4 | S | Indirect | James McLaughlin - Son |
| No | 4 | S | Indirect | James McLaughlin - Son |
| No | 4 | D | Indirect | Mark McLaughlin Jr. - Son |
| No | 4 | S | Indirect | Mark McLaughlin Jr. - Son |
| No | 4 | D | Indirect | Faith McLaughlin - Daughter |
| No | 4 | S | Indirect | Faith McLaughlin - Daughter |
| No | 4 | S | Indirect | Faith McLaughlin - Daughter |
Footnotes
- As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share.
- The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- The Reporting Persons beneficially owns shares through a company owned together with his spouse.
- These shares were sold in a private transaction to JOJ Holdings, Inc., an entity affiliated with Immudyne's President and Chief Executive Officer, Justin Schreiber, in connection with the transactions contemplated by the Legacy Assets Sale Agreement.
- These shares were sold in private transactions in connection with the transactions contemplated by the Legacy Assets Sale Agreement.
Billionaire Hedge Funds
